DexCom Inc (DXCM)
Cash ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 566,300 | 643,700 | 1,194,900 | 623,200 | 642,300 | 698,100 | 735,400 | 716,000 | 1,052,600 | 1,444,300 | 1,158,800 | 733,800 | 817,600 | 673,500 | 530,000 | 584,600 | 446,200 | 395,600 | 709,200 | 1,285,100 |
Short-term investments | US$ in thousands | 2,160,000 | 2,600,000 | 2,440,000 | 1,940,000 | 1,810,000 | 1,670,000 | 2,019,400 | 1,873,000 | 1,360,000 | 1,083,700 | 1,426,100 | 1,898,800 | 1,890,100 | 1,930,300 | 1,978,800 | 925,900 | 1,087,100 | 1,034,300 | 668,300 | 72,900 |
Total current liabilities | US$ in thousands | 1,556,000 | 1,678,600 | 2,069,700 | 1,865,000 | 1,839,300 | 900,500 | 807,000 | 711,400 | 720,800 | 734,900 | 600,700 | 604,100 | 614,100 | 506,400 | 400,100 | 342,800 | 360,200 | 322,400 | 288,200 | 235,400 |
Cash ratio | 1.75 | 1.93 | 1.76 | 1.37 | 1.33 | 2.63 | 3.41 | 3.64 | 3.35 | 3.44 | 4.30 | 4.36 | 4.41 | 5.14 | 6.27 | 4.41 | 4.26 | 4.44 | 4.78 | 5.77 |
December 31, 2023 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($566,300K
+ $2,160,000K)
÷ $1,556,000K
= 1.75
The cash ratio of Dexcom Inc has been fluctuating over the past eight quarters, ranging from a low of 1.42 in Q4 2022 to a high of 4.02 in Q1 2022. The cash ratio provides insight into a company's ability to cover its short-term liabilities with its available cash and cash equivalents. A higher cash ratio indicates a stronger ability to meet these obligations without relying on external sources.
In the most recent quarter, Q4 2023, the cash ratio stands at 1.84, which indicates that Dexcom Inc has $1.84 in cash and cash equivalents for every $1 of its current liabilities. This suggests that the company has a moderate level of liquidity to meet its short-term obligations. However, the decreasing trend in the cash ratio from Q2 2022 to Q4 2023 may warrant further analysis to understand the reasons behind this decline and whether it is a cause for concern in terms of the company's liquidity position.
Peer comparison
Dec 31, 2023